Summary
A bioRxiv preprint reports that ANO6 helps organize contacts between the endoplasmic reticulum and mitochondria, directing vulnerable lipids into protective droplets in chemoresistant breast cancer models. Disrupting the system with niclosamide resensitized models to ferroptosis.
A bioRxiv preprint reports that ANO6 helps resistant breast cancer cells manage peroxidizable lipids by organizing contact sites between the endoplasmic reticulum (ER) and mitochondria. The authors link this arrangement to lipid storage in cytoplasmic droplets and reduced susceptibility to ferroptosis, a form of regulated cell death driven by iron-dependent lipid peroxidation.
The researchers analysed paired breast cancer specimens collected before and after neoadjuvant chemotherapy (NAC), and used engineered ANO6 models, lipid analysis, microscopy and preclinical xenografts. They report that chemoresistant lesions had higher ANO6 levels and accumulated polyunsaturated phospholipids (PUFA-PLs) without a corresponding increase in apoptosis.
ANO6 organizes an organelle contact platform
ER–mitochondria contact sites are regions where the two organelles are closely positioned and can coordinate aspects of cell metabolism. The study describes a role for ANO6 at these sites beyond its canonical function as a plasma-membrane scramblase, a protein that moves lipids between the two layers of a membrane.
According to the authors, ANO6 recruits vimentin (VIM) and VAPB to form a VIM–ANO6–VAPB–PTPIP51 tethering platform. They propose that this complex links intermediate filaments to the organelle contacts and tightens ER–mitochondria coupling. The resulting structure helps route and sequester peroxidizable lipids in cytoplasmic lipid droplets, keeping them away from functional membrane bilayers where their oxidation could contribute to ferroptosis.
Experiments with ANO6 variants supported the importance of its conformation: the I612A variant sustained contact-site integrity and lipid packaging, while D703R compromised the contact architecture. The authors used subcellular lipidomics of purified mitochondria-associated ER membranes, electron microscopy and proximity-ligation assays to examine these structures and interactions.
Niclosamide disrupted lipid sequestration in models
The researchers also tested pharmacological disruption of the ANO6-associated platform. They report that niclosamide destabilized lipid sequestration and selectively resensitized chemoresistant cells to ferroptosis in vitro and in vivo, including in preclinical xenograft models. This points to a possible way to exploit lipid-handling vulnerabilities in resistant tumours, but the reported treatment results are preclinical rather than evidence of benefit in patients.
The work is a bioRxiv preprint. Its abstract describes paired clinical specimens and laboratory and xenograft experiments, but does not state the number of specimens or model cohorts. The results therefore connect a human-tissue pattern with a proposed mechanism tested in experimental models; they do not amount to a clinical treatment study.